PTGX (protagonist-inc.com) Bozor qiymatining balans qiymatiga nisbati
Quyida tasvirlangan Protagonist Therapeutics (PTGX) uchun joriy bozor kotirovkalari innovatsion immun dorilarini ishlab chiquvchi kompaniyaning dinamikasini namoyish etadi. Biznes qat'iy FDA filtrlaridan o'tish uchun murakkab ilmiy asos va patent himoyasiga tayanadi. Samarali boshqaruv bozor yetakchilari bilan ittifoqlar orqali moliyaviy yuklarni kamaytirdi. Joriy ko'rsatkich 10.84 darajasida turibdi, uning noyob platformasining tijoratlashtirilishi esa royalti to'lovlarining barqaror oqimini ta'minlaydi va bozorga bo'lgan pozitsiyasini mustahkamlaydi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_PTGX_-_Protagonist-Therapeutics_-_Market-Capitalization-to-Net-Assets "PTGX Protagonist Corp Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Protagonist Therapeutics, Inc. (PTGX) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Protagonist Therapeutics - PTGX
Ushbu ko'rsatkich umumiy bozor kapitalizatsiyasining sof aktivlar qiymatiga nisbati sifatida hisoblanadi va bu balans qiymatidan yuqori bo'lgan bozor premiumini aks ettiradi. Moliyaviy hisobotlar va bozor kotirovkalari o'rtasidagi ushbu bog'liqlik Protagonist Therapeutics (PTGX) kompaniyasining litsenziyalash daromadlariga oid investorlar kutganlarini baholash imkonini beradi, bu esa kompaniya klinik sinovlarning yakuniy bosqichlariga tayyorgarlik ko'rayotgan bir paytda narxning balans qiymatiga nisbati tendentsiyasida yaqqol namoyon bo'lmoqda.
Asosiy raqobatchilar
Kapitallashuvning sof aktivlarga nisbati argenx SE|BNTX (biontech.de) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Immunovant Corp (IMVT) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Kiniksa Corp (KNSA)|Bozor kapitallashuvining balans qiymatiga nisbati GRFS (Grifols, S.A.)|adaptivebiotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Celldex Therapeutics, Inc. (CLDX)|AUPH: Balans qiymatiga nisbatan bozor qiymati|BCRX (BioCryst Pharmaceuticals Inc) - Bozor qiymatining balans qiymatiga nisbati|Vera Corp (VERA) - Kapitallashuvning sof aktivlarga nisbati|DNTH (Dianthus Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Tourmaline Bio Inc (TRML)|Bozor kapitallashuvining balans qiymatiga nisbati PGEN|Pharming Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|NKTR: Bozor qiymatining balans qiymatiga nisbati|UPB: Kapitallashuvning sof aktivlarga nisbati|ZBIO (Zenas Biopharma) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|GOSS (Gossamer Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KALV|Bozor qiymatining balans qiymatiga nisbati Septerna Inc SEPN|Kapitallashuvning balans qiymatiga nisbati pieris.com (PVLA)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Rigel Pharma - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati AnaptysBio Corp|ATXS: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati enGene Holdings Inc. ENGN|RAPT (rapt.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati JBIO (Aerovate Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Aclaris Therapeutics Inc. (ACRS)|Kapitallashuvning sof aktivlarga nisbati Kyverna|Bozor kapitallashuvining balans qiymatiga multiplikatori Tiziana Life Sciences, Ltd. (TLSA)|Bozor kapitallashuvining balans qiymatiga nisbati CABA (Cabaletta Bio, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati ventyxbio.com VTYX|Bozor kapitallashuvining balans qiymatiga nisbati THTX|AVTX: Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati ELDN|AGEN (Agenus, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Climb Bio Inc (CLYM)|Kapitallashuvning balans qiymatiga nisbati zurabio.com|ATYR (aTyr Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ADAG (adagene.com)|Bozor qiymatining balans qiymatiga nisbati IMA|STTK - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Equillium Bio EQ|Connect Biopharma (CNTB) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati immunic-therapeutics.com IMUX|Balans qiymatiga nisbatan bozor qiymati Atara Bio|InflaRx NV (IFRX) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori X4 Pharmaceuticals, Inc|Adicet Bio (ACET) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati celularity.com (CELU)|INMB: Bozor kapitallashuvining balans qiymatiga nisbati|Barinthus Biotherapeutics PLC - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Kezar Life Sciences, Inc (KZR)|SABS - Balans qiymatiga nisbatan bozor qiymati|AKTX: Bozor kapitallashuvining balans qiymatiga nisbati|ENLV (Enlivex Therapeutics Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc QTTB|Sof aktivlarga nisbatan bozor kapitallashuvi GeoVax Labs|Edesa - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti iBio Corporation IBIO|Kapitallashuvning sof aktivlarga nisbati CARM (Carisma Therapeutics Inc.)|XTLB - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Bolt Bio BOLT|HCWB - Bozor kapitallashuvining balans qiymatiga multiplikatori|aptevotherapeutics.com - Bozor kapitallashuvining balans qiymatiga nisbati|aimimmuno.com (AIM) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ADTX|Kapitallashuvning sof aktivlarga nisbati GRI|XRTX (XORTX Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi HIND (Vyome Holdings Inc.)|Revelation Bio (REVB) - Bozor qiymatining balans qiymatiga nisbati|INDP - Sof aktivlarga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Scinai Immunotherapeutics SCNI|CALI - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati AFMD (affimed.com)|Bozor qiymatining xususiy kapitalga nisbati Allakos|Kapitallashuvning sof aktivlarga nisbati HOOKIPA Pharma, Inc. (HOOK)|Kapitallashuvning balans qiymatiga nisbati IGMS|ITOS - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TC BioPharm|Balans qiymatiga nisbatan bozor qiymati Third Harmonic Bio Inc. THRD